Assay News and Research

RSS
Study identifies four new monoclonal antibodies with broad neutralizing potencies that target conserved SARS-CoV-2 epitopes

Study identifies four new monoclonal antibodies with broad neutralizing potencies that target conserved SARS-CoV-2 epitopes

20 Dec 2022
First H5N3 infection in a captive emperor tamarin documented in new study

First H5N3 infection in a captive emperor tamarin documented in new study

19 Dec 2022
Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

19 Dec 2022
Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

19 Dec 2022
An assessment of T cell and antibody immunity against SARS-CoV-2 VOCs and the effect of booster shots

An assessment of T cell and antibody immunity against SARS-CoV-2 VOCs and the effect of booster shots

18 Dec 2022
Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

Study shows SARS-CoV-2 infection, replication and persistence in human brain tissues

16 Dec 2022
Scientists identify a novel epitope at the SARS-CoV-2 spike furin cleavage site

Scientists identify a novel epitope at the SARS-CoV-2 spike furin cleavage site

15 Dec 2022
Exploring dynamics of emergence and spread of SARS-CoV-2 variants of concern

Exploring dynamics of emergence and spread of SARS-CoV-2 variants of concern

15 Dec 2022
Sheep milk could be an inexpensive source of therapeutic polyclonal SARS-CoV-2 neutralizing antibodies

Sheep milk could be an inexpensive source of therapeutic polyclonal SARS-CoV-2 neutralizing antibodies

15 Dec 2022
How is the host’s m6A mRNA profile affected during SARS-CoV-2 infection?

How is the host’s m6A mRNA profile affected during SARS-CoV-2 infection?

15 Dec 2022
Major treatment advance revealed for adults with newly diagnosed B lineage acute lymphoblastic leukemia

Major treatment advance revealed for adults with newly diagnosed B lineage acute lymphoblastic leukemia

14 Dec 2022
Study indicates need for developing mucosal vaccines to induce potent immune responses at sites where SARS-CoV-2 infection occurs

Study indicates need for developing mucosal vaccines to induce potent immune responses at sites where SARS-CoV-2 infection occurs

14 Dec 2022
Overview of current methods, technologies, and applications in the molecular diagnosis of mpox

Overview of current methods, technologies, and applications in the molecular diagnosis of mpox

13 Dec 2022
Study suggests persistent inflammatory response triggered by SARS-CoV-2 may be responsible for observed sequelae in PASC patients

Study suggests persistent inflammatory response triggered by SARS-CoV-2 may be responsible for observed sequelae in PASC patients

13 Dec 2022
Scientists use single-cell multi-omics data to map disease regulatory circuits

Scientists use single-cell multi-omics data to map disease regulatory circuits

12 Dec 2022
Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

12 Dec 2022
Quanterix’s Simoa® technology drives advances in Alzheimer’s disease research presented at 2022 Clinical Trials On Alzheimer’s Disease (CTAD) conference

Quanterix’s Simoa® technology drives advances in Alzheimer’s disease research presented at 2022 Clinical Trials On Alzheimer’s Disease (CTAD) conference

From Quanterix 12 Dec 2022
Reports of Mpox disease following recent vaccination

Reports of Mpox disease following recent vaccination

11 Dec 2022
Characterization of SARS-CoV-2 Omicron BQ.1.1

Characterization of SARS-CoV-2 Omicron BQ.1.1

9 Dec 2022
What are the associations of metabolome, microbiome, and immune perturbations with severe COVID-19?

What are the associations of metabolome, microbiome, and immune perturbations with severe COVID-19?

8 Dec 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback